Keywords: amgen, acquires, alantos, 300m, leading, biotechnology, firm

Amgen acquires Alantos for $300M

Article | 18 June 2007

Print This

Leading US biotechnology firm Amgen has agreed to acquire Alantos, a private company developing drugs for the treatment of diabetes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in